Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”

[摘要] We thank Y.P. Moodley and co-workers for their thoughtful letter in response to our manuscript on the natural history of progressive fibrosing interstitial lung diseases (ILDs) [1]. We agree that early identification of patients with progression of their ILD is important to enable prompt implementation of appropriate treatment. The inclusion criteria for the INBUILD trial reflected current approaches used to identify patients with progressive ILD. However, we acknowledge that the pattern of progression of ILD varies among individual patients, and no single set of criteria will capture all of them.

[学科分类] 呼吸医学